Nanoparticles for radiooncology: Mission, vision, challenges
LA Kunz-Schughart, A Dubrovska, C Peitzsch, A Ewe… - Biomaterials, 2017 - Elsevier
Cancer is one of the leading non-communicable diseases with highest mortality rates
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
[PDF][PDF] Nanoparticles for Radiooncology: Mission, Vision, Challenges
LA Kunz-Schughart, A Dubrovska, C Peitzsch, A Ewe… - Biomaterials, 2017 - hzdr.de
Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Nanoparticles for radiooncology: Mission,
vision, challenges. Page 1 Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Nanoparticles for …
vision, challenges. Page 1 Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Nanoparticles for …
Nanoparticles for radiooncology: Mission, vision, challenges.
LA Kunz-Schughart, A Dubrovska, C Peitzsch, A Ewe… - Biomaterials, 2016 - europepmc.org
Cancer is one of the leading non-communicable diseases with highest mortality rates
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
[PDF][PDF] Nanoparticles for Radiooncology: Mission, Vision, Challenges
LA Kunz-Schughart, A Dubrovska, C Peitzsch, A Ewe… - Biomaterials, 2017 - academia.edu
Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Nanoparticles for radiooncology: Mission,
vision, challenges. Page 1 Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Nanoparticles for …
vision, challenges. Page 1 Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Nanoparticles for …
Nanoparticles for radiooncology: Mission, vision, challenges
KS LA, A Dubrovska, C Peitzsch, A Ewe, A Aigner… - BIOMATERIALS, 2017 - iris.unical.it
Cancer is one of the leading non-communicable diseases with highest mortality rates
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
Nanoparticles for radiooncology: Mission, vision, challenges
LA Kunz-Schughart, A Dubrovska, C Peitzsch, A Ewe… - Biomaterials, 2017 - infona.pl
Cancer is one of the leading non-communicable diseases with highest mortality rates
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
Nanoparticles for radiooncology: Mission, vision, challenges
LA Kunz-Schughart, A Dubrovska, C Peitzsch… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Cancer is one of the leading non-communicable diseases with highest mortality rates
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
[引用][C] Nanoparticles for radiooncology: Mission, vision, challenges
LA Kunz-Schughart, A Dubrovska, C Peitzsch, A Ewe… - Biomaterials, 2017 - cir.nii.ac.jp
Nanoparticles for radiooncology: Mission, vision, challenges | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Nanoparticles for radiooncology: Mission, vision, challenges.
L Kunz-Schughart, A Dubrovska, C Peitzsch, A Ewe… - Biomaterials, 2016 - hzdr.de
Cancer is one of the leading non-communicable diseases with highest mortality rates
worldwide. About half of all cancer patients receive radiation treatment in the course of their …
worldwide. About half of all cancer patients receive radiation treatment in the course of their …